Alliance Pharma Management
Management criteria checks 3/4
Alliance Pharma's CEO is Andrew Franklin, appointed in Sep 2015, has a tenure of 8.67 years. total yearly compensation is £271.52K, comprised of 88.1% salary and 11.9% bonuses, including company stock and options. directly owns 0.036% of the company’s shares, worth £65.59K. The average tenure of the management team and the board of directors is 4.1 years and 1.3 years respectively.
Key information
Andrew Franklin
Chief executive officer
UK£271.5k
Total compensation
| CEO salary percentage | 88.1% |
| CEO tenure | 8.7yrs |
| CEO ownership | 0.04% |
| Management average tenure | 4.1yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet
Feb 23
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)
Nov 21We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt
May 26Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models
Mar 24We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt
Sep 30An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued
May 28Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet
Mar 30Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?
Dec 24Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?
Nov 19
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -UK£7m |
| Mar 31 2023 | n/a | n/a | -UK£3m |
| Dec 31 2022 | UK£272k | UK£239k | UK£936k |
| Sep 30 2022 | n/a | n/a | UK£7m |
| Jun 30 2022 | n/a | n/a | UK£12m |
| Mar 31 2022 | n/a | n/a | UK£10m |
| Dec 31 2021 | UK£417k | UK£227k | UK£7m |
| Sep 30 2021 | n/a | n/a | UK£13m |
| Jun 30 2021 | n/a | n/a | UK£18m |
| Mar 31 2021 | n/a | n/a | UK£13m |
| Dec 31 2020 | UK£349k | UK£210k | UK£8m |
| Sep 30 2020 | n/a | n/a | UK£10m |
| Jun 30 2020 | n/a | n/a | UK£11m |
| Mar 31 2020 | n/a | n/a | UK£18m |
| Dec 31 2019 | UK£779k | UK£186k | UK£25m |
| Sep 30 2019 | n/a | n/a | UK£23m |
| Jun 30 2019 | n/a | n/a | UK£21m |
| Mar 31 2019 | n/a | n/a | UK£20m |
| Dec 31 2018 | UK£242k | UK£175k | UK£18m |
| Sep 30 2018 | n/a | n/a | UK£21m |
| Jun 30 2018 | n/a | n/a | UK£24m |
| Mar 31 2018 | n/a | n/a | UK£27m |
| Dec 31 2017 | UK£227k | UK£165k | UK£29m |
Compensation vs Market: Andrew's total compensation ($USD339.73K) is below average for companies of similar size in the UK market ($USD784.60K).
Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.
CEO
Andrew Franklin (57 yo)
8.7yrs
Tenure
UK£271,520
Compensation
Mr. Andrew Timothy Franklin has been the Chief Financial Officer of Alliance Pharma plc since September 28, 2015 and its Interim Chief Executive Officer since November 23, 2022. Mr. Franklin joined Allianc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO | 8.7yrs | UK£271.52k | 0.036% £ 65.6k | |
| CEO & Executive Director (Leave of Absence) | 1.5yrs | UK£399.83k | 0.086% £ 158.5k | |
| COO & Director | 1.3yrs | no data | no data | |
| Chief Scientific Affairs Officer | no data | no data | no data | |
| Head of Investor Relations & Corporate Communications | no data | no data | no data | |
| Group General Counsel & Company Secretary | 6.7yrs | no data | no data | |
| Chief Commercial & Corporate Development Officer | no data | no data | no data | |
| Chief People Officer | 1.3yrs | no data | no data | |
| Global Marketing Head of Kelo-Cote | 7.3yrs | no data | no data | |
| Head of Sourcing | no data | no data | no data |
4.1yrs
Average Tenure
49yo
Average Age
Experienced Management: APH's management team is considered experienced (4.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO | 8.7yrs | UK£271.52k | 0.036% £ 65.6k | |
| COO & Director | 1.3yrs | no data | no data | |
| Independent Non-Executive Director | 1.3yrs | no data | no data | |
| Senior Independent Non-Executive Director | 5.3yrs | UK£49.46k | 0.013% £ 23.1k | |
| Independent Non Executive Chair | less than a year | no data | no data | |
| Independent Non-Executive Director | 2.4yrs | UK£47.20k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
1.3yrs
Average Tenure
54yo
Average Age
Experienced Board: APH's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.